Corcept Therapeutics (CORT) Inventory (2012 - 2026)

Corcept Therapeutics (CORT) has 15 years of Inventory data on file, last reported at $12.9 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 10.29% year-over-year to $12.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (down 10.29% YoY), and the FY2025 full-year result was $12.9 million, up 3.67% from the prior year.
• Inventory was little changed at $12.9 million in Q1 2026, from $12.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $14.4 million in Q1 2025 to a low of $5.1 million in Q1 2022.
• A 5-year average of $8.9 million and a median of $7.7 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory surged 99.83% in 2025 and dropped 10.29% in 2026, its largest moves.
• Tracing CORT's Inventory over 5 years: stood at $6.1 million in 2022, then climbed by 26.72% to $7.7 million in 2023, then surged by 60.57% to $12.4 million in 2024, then rose by 3.67% to $12.9 million in 2025, then grew by 0.17% to $12.9 million in 2026.
• Business Quant data shows CORT's Inventory at $12.9 million in Q1 2026, $12.9 million in Q4 2025, and $12.3 million in Q3 2025.